[{"edinetCode":"E27585","endDate":"2017\/3\/31","Report abbreviation_x":"asr","context_x":"当期連結時点","numberOfEmployee":60.0,"averageTemporaryStaff":16.0,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":6835674.0,"sharesOwendPercent":0.1121,"outstandingShares":null,"numberOfSubsidiary":3.0,"bps":120.87,"equityRatio":0.937,"cashAndCashEquivalents":5419992000.0,"assets":7854116000.0,"currentAssets":5910725000.0,"fixedAsset":1943390000.0,"tangibleFixedAssets":95787000.0,"intangibleFixedAssets":1469211000.0,"investmentAndOtherAssets":378392000.0,"liabilities":485595000.0,"currentLiabilities":281889000.0,"shorTermDept":2801000.0,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":null,"fixedLiabilities":203706000.0,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":82854000.0,"netAsset":7368520000.0,"capitalStock":7403954000.0,"capital":5490327000.0,"capitalSurplus":6343627000.0,"accumulatedEarnings":-4429085000.0,"treasuryStock":-915000.0,"valuationAndConversionAdjustments":-43680000.0,"Report abbreviation_y":"asr","context_y":"当期連結期間","Sales":1257812000.0,"costOfSales":681740000.0,"grossProfit":576072000.0,"sgaExpenses":1520376000.0,"salaryAndBenefit":295728000.0,"depreciationAndSGA":92001000.0,"RDExpenses":276449000.0,"operatingIncome":-944304000.0,"nonOperatingIncome":82648000.0,"nonOperatingExpenses":75421000.0,"interestExpense":325000.0,"ordinaryProfit":-937078000.0,"extraordinaryGain":null,"extraordinaryLoss":null,"incomeBeforeTax":-937078000.0,"incomeTaxes":-25413000.0,"netIncome":-911664000.0,"netIncomeAttributableToOwnersOfTheParentCompany":-911664000.0,"comprehensiveIncome":-1031584000.0,"eps":-15.68,"dilutedEps":null,"dividendPerShare":null,"per":null,"roe":null,"cashFlowFromOperatingActivities":-775025000.0,"depreciationAndCashflowFromOperatingActivities":113594000.0,"cashFlowFromInvestingActivities":685715000.0,"cashFlowFromFinancialActivities":1127662000.0,"changesInCashAndCashEquivalents":1004105000.0,"列1":"asr","submitDate":"2017\/6\/26","stockCode":4978,"accountingYear":"第15期（自　平成28年４月１日　至　平成29年３月31日）","accountingYearStart":"2016\/4\/1","accountingYearEnd":"2017\/3\/31","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E27585","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":2955,"settlementDate":"2022\/3\/31","submitterName":"株式会社リプロセル","submitterNameEnglish":"ReproCELL Incorporated","submitterNameKana":"カブシキガイシャリプロセル","location":"横浜市港北区新横浜３－８－１１","industory":"化学","corporateNumber":2020000000000.0},{"edinetCode":"E27585","endDate":"2018\/3\/31","Report abbreviation_x":"asr","context_x":"当期連結時点","numberOfEmployee":63.0,"averageTemporaryStaff":16.0,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":5898200.0,"sharesOwendPercent":0.0923,"outstandingShares":null,"numberOfSubsidiary":3.0,"bps":97.76,"equityRatio":0.943,"cashAndCashEquivalents":5580003000.0,"assets":6597797000.0,"currentAssets":5979893000.0,"fixedAsset":617904000.0,"tangibleFixedAssets":72111000.0,"intangibleFixedAssets":1486000.0,"investmentAndOtherAssets":544305000.0,"liabilities":349379000.0,"currentLiabilities":261016000.0,"shorTermDept":null,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":2480000.0,"fixedLiabilities":88363000.0,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":80000000.0,"netAsset":6248418000.0,"capitalStock":6271581000.0,"capital":6010164000.0,"capitalSurplus":6863463000.0,"accumulatedEarnings":-6601131000.0,"treasuryStock":-915000.0,"valuationAndConversionAdjustments":-49099000.0,"Report abbreviation_y":"asr","context_y":"当期連結期間","Sales":926255000.0,"costOfSales":545050000.0,"grossProfit":381204000.0,"sgaExpenses":1406987000.0,"salaryAndBenefit":278167000.0,"depreciationAndSGA":100879000.0,"RDExpenses":191634000.0,"operatingIncome":-1025782000.0,"nonOperatingIncome":107137000.0,"nonOperatingExpenses":16402000.0,"interestExpense":993000.0,"ordinaryProfit":-935047000.0,"extraordinaryGain":null,"extraordinaryLoss":1346508000.0,"incomeBeforeTax":-2281556000.0,"incomeTaxes":-109510000.0,"netIncome":-2172046000.0,"netIncomeAttributableToOwnersOfTheParentCompany":-2172046000.0,"comprehensiveIncome":-2177465000.0,"eps":-34.28,"dilutedEps":null,"dividendPerShare":null,"per":null,"roe":null,"cashFlowFromOperatingActivities":-636720000.0,"depreciationAndCashflowFromOperatingActivities":119844000.0,"cashFlowFromInvestingActivities":-228023000.0,"cashFlowFromFinancialActivities":1028650000.0,"changesInCashAndCashEquivalents":160011000.0,"列1":"asr","submitDate":"2018\/6\/25","stockCode":4978,"accountingYear":"第16期（自　2017年４月１日　至　2018年３月31日）","accountingYearStart":"2017\/4\/1","accountingYearEnd":"2018\/3\/31","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E27585","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":2955,"settlementDate":"2022\/3\/31","submitterName":"株式会社リプロセル","submitterNameEnglish":"ReproCELL Incorporated","submitterNameKana":"カブシキガイシャリプロセル","location":"横浜市港北区新横浜３－８－１１","industory":"化学","corporateNumber":2020000000000.0},{"edinetCode":"E27585","endDate":"2019\/3\/31","Report abbreviation_x":"asr","context_x":"当期連結時点","numberOfEmployee":111.0,"averageTemporaryStaff":5.0,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":7656108.0,"sharesOwendPercent":0.1077,"outstandingShares":null,"numberOfSubsidiary":6.0,"bps":99.5,"equityRatio":0.937,"cashAndCashEquivalents":4112750000.0,"assets":7489998000.0,"currentAssets":6202302000.0,"fixedAsset":1287696000.0,"tangibleFixedAssets":178605000.0,"intangibleFixedAssets":112599000.0,"investmentAndOtherAssets":996492000.0,"liabilities":418848000.0,"currentLiabilities":330417000.0,"shorTermDept":null,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":null,"fixedLiabilities":88430000.0,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":80000000.0,"netAsset":7071150000.0,"capitalStock":7087791000.0,"capital":6718920000.0,"capitalSurplus":7572342000.0,"accumulatedEarnings":-7202556000.0,"treasuryStock":-915000.0,"valuationAndConversionAdjustments":-70209000.0,"Report abbreviation_y":"asr","context_y":"当期連結期間","Sales":1088527000.0,"costOfSales":592074000.0,"grossProfit":496453000.0,"sgaExpenses":1277571000.0,"salaryAndBenefit":295808000.0,"depreciationAndSGA":22751000.0,"RDExpenses":273219000.0,"operatingIncome":-781118000.0,"nonOperatingIncome":158290000.0,"nonOperatingExpenses":4264000.0,"interestExpense":644000.0,"ordinaryProfit":-627091000.0,"extraordinaryGain":null,"extraordinaryLoss":null,"incomeBeforeTax":-627091000.0,"incomeTaxes":1413000.0,"netIncome":-628505000.0,"netIncomeAttributableToOwnersOfTheParentCompany":-601424000.0,"comprehensiveIncome":-649615000.0,"eps":-8.79,"dilutedEps":null,"dividendPerShare":null,"per":null,"roe":null,"cashFlowFromOperatingActivities":-554831000.0,"depreciationAndCashflowFromOperatingActivities":40595000.0,"cashFlowFromInvestingActivities":-2308145000.0,"cashFlowFromFinancialActivities":1381166000.0,"changesInCashAndCashEquivalents":-1467253000.0,"列1":"asr","submitDate":"2019\/6\/28","stockCode":4978,"accountingYear":"第17期（自　2018年４月１日　至　2019年３月31日）","accountingYearStart":"2018\/4\/1","accountingYearEnd":"2019\/3\/31","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E27585","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":2955,"settlementDate":"2022\/3\/31","submitterName":"株式会社リプロセル","submitterNameEnglish":"ReproCELL Incorporated","submitterNameKana":"カブシキガイシャリプロセル","location":"横浜市港北区新横浜３－８－１１","industory":"化学","corporateNumber":2020000000000.0},{"edinetCode":"E27585","endDate":"2019\/6\/30","Report abbreviation_x":"q1r","context_x":"当四半期会計期間連結時点","numberOfEmployee":null,"averageTemporaryStaff":null,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":null,"sharesOwendPercent":null,"outstandingShares":null,"numberOfSubsidiary":null,"bps":null,"equityRatio":0.947,"cashAndCashEquivalents":null,"assets":7170288000.0,"currentAssets":6236759000.0,"fixedAsset":933528000.0,"tangibleFixedAssets":164631000.0,"intangibleFixedAssets":107264000.0,"investmentAndOtherAssets":661632000.0,"liabilities":347557000.0,"currentLiabilities":258755000.0,"shorTermDept":null,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":null,"fixedLiabilities":88801000.0,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":80000000.0,"netAsset":6822731000.0,"capitalStock":6890141000.0,"capital":6735064000.0,"capitalSurplus":7588486000.0,"accumulatedEarnings":-7432494000.0,"treasuryStock":-915000.0,"valuationAndConversionAdjustments":-96904000.0,"Report abbreviation_y":"q1r","context_y":"当四半期累計期間連結期間","Sales":256715000.0,"costOfSales":150870000.0,"grossProfit":105845000.0,"sgaExpenses":331787000.0,"salaryAndBenefit":null,"depreciationAndSGA":null,"RDExpenses":90023000.0,"operatingIncome":-225942000.0,"nonOperatingIncome":30558000.0,"nonOperatingExpenses":34249000.0,"interestExpense":101000.0,"ordinaryProfit":-229633000.0,"extraordinaryGain":null,"extraordinaryLoss":null,"incomeBeforeTax":-229633000.0,"incomeTaxes":471000.0,"netIncome":-230104000.0,"netIncomeAttributableToOwnersOfTheParentCompany":-229937000.0,"comprehensiveIncome":-257038000.0,"eps":-3.23,"dilutedEps":null,"dividendPerShare":null,"per":null,"roe":null,"cashFlowFromOperatingActivities":null,"depreciationAndCashflowFromOperatingActivities":null,"cashFlowFromInvestingActivities":null,"cashFlowFromFinancialActivities":null,"changesInCashAndCashEquivalents":null,"列1":"q1r","submitDate":"2019\/8\/9","stockCode":4978,"accountingYear":null,"accountingYearStart":"2019\/4\/1","accountingYearEnd":"2020\/3\/31","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E27585","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":2955,"settlementDate":"2022\/3\/31","submitterName":"株式会社リプロセル","submitterNameEnglish":"ReproCELL Incorporated","submitterNameKana":"カブシキガイシャリプロセル","location":"横浜市港北区新横浜３－８－１１","industory":"化学","corporateNumber":2020000000000.0},{"edinetCode":"E27585","endDate":"2019\/9\/30","Report abbreviation_x":"q2r","context_x":"当四半期会計期間連結時点","numberOfEmployee":null,"averageTemporaryStaff":null,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":6865994.0,"sharesOwendPercent":0.0965,"outstandingShares":null,"numberOfSubsidiary":null,"bps":null,"equityRatio":0.939,"cashAndCashEquivalents":3697695000.0,"assets":7000290000.0,"currentAssets":6087265000.0,"fixedAsset":913024000.0,"tangibleFixedAssets":170432000.0,"intangibleFixedAssets":105177000.0,"investmentAndOtherAssets":637414000.0,"liabilities":399478000.0,"currentLiabilities":310435000.0,"shorTermDept":null,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":null,"fixedLiabilities":89042000.0,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":80000000.0,"netAsset":6600812000.0,"capitalStock":6684600000.0,"capital":6736149000.0,"capitalSurplus":7588017000.0,"accumulatedEarnings":-7638651000.0,"treasuryStock":-915000.0,"valuationAndConversionAdjustments":-110420000.0,"Report abbreviation_y":"q2r","context_y":"当四半期累計期間連結期間","Sales":564830000.0,"costOfSales":333265000.0,"grossProfit":231565000.0,"sgaExpenses":663850000.0,"salaryAndBenefit":173802000.0,"depreciationAndSGA":null,"RDExpenses":194766000.0,"operatingIncome":-432284000.0,"nonOperatingIncome":45097000.0,"nonOperatingExpenses":47525000.0,"interestExpense":177000.0,"ordinaryProfit":-434712000.0,"extraordinaryGain":null,"extraordinaryLoss":null,"incomeBeforeTax":-434712000.0,"incomeTaxes":1556000.0,"netIncome":-436269000.0,"netIncomeAttributableToOwnersOfTheParentCompany":-436095000.0,"comprehensiveIncome":-476911000.0,"eps":-6.13,"dilutedEps":null,"dividendPerShare":null,"per":null,"roe":null,"cashFlowFromOperatingActivities":-364242000.0,"depreciationAndCashflowFromOperatingActivities":26175000.0,"cashFlowFromInvestingActivities":11555000.0,"cashFlowFromFinancialActivities":6408000.0,"changesInCashAndCashEquivalents":-415055000.0,"列1":"q2r","submitDate":"2019\/11\/13","stockCode":4978,"accountingYear":null,"accountingYearStart":"2019\/4\/1","accountingYearEnd":"2020\/3\/31","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E27585","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":2955,"settlementDate":"2022\/3\/31","submitterName":"株式会社リプロセル","submitterNameEnglish":"ReproCELL Incorporated","submitterNameKana":"カブシキガイシャリプロセル","location":"横浜市港北区新横浜３－８－１１","industory":"化学","corporateNumber":2020000000000.0},{"edinetCode":"E27585","endDate":"2019\/12\/31","Report abbreviation_x":"q3r","context_x":"当四半期会計期間連結時点","numberOfEmployee":null,"averageTemporaryStaff":null,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":null,"sharesOwendPercent":null,"outstandingShares":null,"numberOfSubsidiary":null,"bps":null,"equityRatio":0.936,"cashAndCashEquivalents":null,"assets":6883633000.0,"currentAssets":5931289000.0,"fixedAsset":952344000.0,"tangibleFixedAssets":210039000.0,"intangibleFixedAssets":118316000.0,"investmentAndOtherAssets":623988000.0,"liabilities":433475000.0,"currentLiabilities":344651000.0,"shorTermDept":null,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":null,"fixedLiabilities":88823000.0,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":80000000.0,"netAsset":6450158000.0,"capitalStock":6519482000.0,"capital":6767487000.0,"capitalSurplus":7619355000.0,"accumulatedEarnings":-7866445000.0,"treasuryStock":-915000.0,"valuationAndConversionAdjustments":-77565000.0,"Report abbreviation_y":"q3r","context_y":"当四半期累計期間連結期間","Sales":891526000.0,"costOfSales":582264000.0,"grossProfit":309262000.0,"sgaExpenses":980867000.0,"salaryAndBenefit":null,"depreciationAndSGA":null,"RDExpenses":323249000.0,"operatingIncome":-671605000.0,"nonOperatingIncome":51380000.0,"nonOperatingExpenses":36450000.0,"interestExpense":257000.0,"ordinaryProfit":-656675000.0,"extraordinaryGain":null,"extraordinaryLoss":5617000.0,"incomeBeforeTax":-662292000.0,"incomeTaxes":2013000.0,"netIncome":-664306000.0,"netIncomeAttributableToOwnersOfTheParentCompany":-663888000.0,"comprehensiveIncome":-671811000.0,"eps":-9.32,"dilutedEps":null,"dividendPerShare":null,"per":null,"roe":null,"cashFlowFromOperatingActivities":null,"depreciationAndCashflowFromOperatingActivities":null,"cashFlowFromInvestingActivities":null,"cashFlowFromFinancialActivities":null,"changesInCashAndCashEquivalents":null,"列1":"q3r","submitDate":"2020\/2\/13","stockCode":4978,"accountingYear":null,"accountingYearStart":"2019\/4\/1","accountingYearEnd":"2020\/3\/31","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E27585","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":2955,"settlementDate":"2022\/3\/31","submitterName":"株式会社リプロセル","submitterNameEnglish":"ReproCELL Incorporated","submitterNameKana":"カブシキガイシャリプロセル","location":"横浜市港北区新横浜３－８－１１","industory":"化学","corporateNumber":2020000000000.0},{"edinetCode":"E27585","endDate":"2020\/3\/31","Report abbreviation_x":"asr","context_x":"当期連結時点","numberOfEmployee":113.0,"averageTemporaryStaff":8.0,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":null,"sharesOwendPercent":null,"outstandingShares":null,"numberOfSubsidiary":7.0,"bps":84.76,"equityRatio":0.923,"cashAndCashEquivalents":4585626000.0,"assets":6553042000.0,"currentAssets":5730970000.0,"fixedAsset":822071000.0,"tangibleFixedAssets":188000000.0,"intangibleFixedAssets":42917000.0,"investmentAndOtherAssets":591154000.0,"liabilities":494895000.0,"currentLiabilities":406941000.0,"shorTermDept":null,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":null,"fixedLiabilities":87953000.0,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":80000000.0,"netAsset":6058146000.0,"capitalStock":6166850000.0,"capital":6767487000.0,"capitalSurplus":7619355000.0,"accumulatedEarnings":-8219076000.0,"treasuryStock":-915000.0,"valuationAndConversionAdjustments":-116280000.0,"Report abbreviation_y":"asr","context_y":"当期連結期間","Sales":1199909000.0,"costOfSales":725201000.0,"grossProfit":474707000.0,"sgaExpenses":1383644000.0,"salaryAndBenefit":331964000.0,"depreciationAndSGA":29945000.0,"RDExpenses":454756000.0,"operatingIncome":-908936000.0,"nonOperatingIncome":92222000.0,"nonOperatingExpenses":75078000.0,"interestExpense":336000.0,"ordinaryProfit":-891792000.0,"extraordinaryGain":null,"extraordinaryLoss":123391000.0,"incomeBeforeTax":-1015183000.0,"incomeTaxes":2125000.0,"netIncome":-1017309000.0,"netIncomeAttributableToOwnersOfTheParentCompany":-1016520000.0,"comprehensiveIncome":-1063822000.0,"eps":-14.27,"dilutedEps":null,"dividendPerShare":null,"per":null,"roe":null,"cashFlowFromOperatingActivities":-689803000.0,"depreciationAndCashflowFromOperatingActivities":54787000.0,"cashFlowFromInvestingActivities":1217887000.0,"cashFlowFromFinancialActivities":6566000.0,"changesInCashAndCashEquivalents":472875000.0,"列1":"asr","submitDate":"2020\/8\/28","stockCode":4978,"accountingYear":"第18期（自　2019年４月１日　至　2020年３月31日）","accountingYearStart":"2019\/4\/1","accountingYearEnd":"2020\/3\/31","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E27585","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":2955,"settlementDate":"2022\/3\/31","submitterName":"株式会社リプロセル","submitterNameEnglish":"ReproCELL Incorporated","submitterNameKana":"カブシキガイシャリプロセル","location":"横浜市港北区新横浜３－８－１１","industory":"化学","corporateNumber":2020000000000.0},{"edinetCode":"E27585","endDate":"2020\/6\/30","Report abbreviation_x":"q1r","context_x":"当四半期会計期間連結時点","numberOfEmployee":null,"averageTemporaryStaff":null,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":null,"sharesOwendPercent":null,"outstandingShares":null,"numberOfSubsidiary":null,"bps":null,"equityRatio":0.914,"cashAndCashEquivalents":null,"assets":6391616000.0,"currentAssets":5594433000.0,"fixedAsset":797182000.0,"tangibleFixedAssets":173725000.0,"intangibleFixedAssets":40312000.0,"investmentAndOtherAssets":583144000.0,"liabilities":543087000.0,"currentLiabilities":455021000.0,"shorTermDept":null,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":null,"fixedLiabilities":88066000.0,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":80000000.0,"netAsset":5848528000.0,"capitalStock":5958783000.0,"capital":6767487000.0,"capitalSurplus":7619355000.0,"accumulatedEarnings":-8427144000.0,"treasuryStock":-915000.0,"valuationAndConversionAdjustments":-117492000.0,"Report abbreviation_y":"q1r","context_y":"当四半期累計期間連結期間","Sales":168264000.0,"costOfSales":128395000.0,"grossProfit":39868000.0,"sgaExpenses":329421000.0,"salaryAndBenefit":null,"depreciationAndSGA":null,"RDExpenses":118304000.0,"operatingIncome":-289552000.0,"nonOperatingIncome":88077000.0,"nonOperatingExpenses":6413000.0,"interestExpense":80000.0,"ordinaryProfit":-207888000.0,"extraordinaryGain":null,"extraordinaryLoss":null,"incomeBeforeTax":-207888000.0,"incomeTaxes":483000.0,"netIncome":-208372000.0,"netIncomeAttributableToOwnersOfTheParentCompany":-208067000.0,"comprehensiveIncome":-209618000.0,"eps":-2.91,"dilutedEps":null,"dividendPerShare":null,"per":null,"roe":null,"cashFlowFromOperatingActivities":null,"depreciationAndCashflowFromOperatingActivities":null,"cashFlowFromInvestingActivities":null,"cashFlowFromFinancialActivities":null,"changesInCashAndCashEquivalents":null,"列1":"q1r","submitDate":"2020\/9\/29","stockCode":4978,"accountingYear":null,"accountingYearStart":"2020\/4\/1","accountingYearEnd":"2021\/3\/31","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E27585","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":2955,"settlementDate":"2022\/3\/31","submitterName":"株式会社リプロセル","submitterNameEnglish":"ReproCELL Incorporated","submitterNameKana":"カブシキガイシャリプロセル","location":"横浜市港北区新横浜３－８－１１","industory":"化学","corporateNumber":2020000000000.0},{"edinetCode":"E27585","endDate":"2020\/9\/30","Report abbreviation_x":"q2r","context_x":"当四半期会計期間連結時点","numberOfEmployee":null,"averageTemporaryStaff":null,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":6814173.0,"sharesOwendPercent":0.0954,"outstandingShares":null,"numberOfSubsidiary":null,"bps":null,"equityRatio":0.904,"cashAndCashEquivalents":3858434000.0,"assets":6300574000.0,"currentAssets":5530999000.0,"fixedAsset":769574000.0,"tangibleFixedAssets":174662000.0,"intangibleFixedAssets":37707000.0,"investmentAndOtherAssets":557205000.0,"liabilities":600425000.0,"currentLiabilities":512239000.0,"shorTermDept":null,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":null,"fixedLiabilities":88185000.0,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":80000000.0,"netAsset":5700149000.0,"capitalStock":5803191000.0,"capital":6768642000.0,"capitalSurplus":7620510000.0,"accumulatedEarnings":-8585046000.0,"treasuryStock":-915000.0,"valuationAndConversionAdjustments":-110133000.0,"Report abbreviation_y":"q2r","context_y":"当四半期累計期間連結期間","Sales":614988000.0,"costOfSales":379304000.0,"grossProfit":235684000.0,"sgaExpenses":737827000.0,"salaryAndBenefit":148067000.0,"depreciationAndSGA":null,"RDExpenses":298630000.0,"operatingIncome":-502142000.0,"nonOperatingIncome":140508000.0,"nonOperatingExpenses":3889000.0,"interestExpense":161000.0,"ordinaryProfit":-365522000.0,"extraordinaryGain":null,"extraordinaryLoss":null,"incomeBeforeTax":-365522000.0,"incomeTaxes":870000.0,"netIncome":-366393000.0,"netIncomeAttributableToOwnersOfTheParentCompany":-365969000.0,"comprehensiveIncome":-360307000.0,"eps":-5.13,"dilutedEps":null,"dividendPerShare":null,"per":null,"roe":null,"cashFlowFromOperatingActivities":-348857000.0,"depreciationAndCashflowFromOperatingActivities":28917000.0,"cashFlowFromInvestingActivities":-381244000.0,"cashFlowFromFinancialActivities":2310000.0,"changesInCashAndCashEquivalents":-727192000.0,"列1":"q2r","submitDate":"2020\/11\/12","stockCode":4978,"accountingYear":null,"accountingYearStart":"2020\/4\/1","accountingYearEnd":"2021\/3\/31","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E27585","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":2955,"settlementDate":"2022\/3\/31","submitterName":"株式会社リプロセル","submitterNameEnglish":"ReproCELL Incorporated","submitterNameKana":"カブシキガイシャリプロセル","location":"横浜市港北区新横浜３－８－１１","industory":"化学","corporateNumber":2020000000000.0},{"edinetCode":"E27585","endDate":"2020\/12\/31","Report abbreviation_x":"q3r","context_x":"当四半期会計期間連結時点","numberOfEmployee":null,"averageTemporaryStaff":null,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":null,"sharesOwendPercent":null,"outstandingShares":null,"numberOfSubsidiary":null,"bps":null,"equityRatio":0.908,"cashAndCashEquivalents":null,"assets":6012143000.0,"currentAssets":5219630000.0,"fixedAsset":792512000.0,"tangibleFixedAssets":166393000.0,"intangibleFixedAssets":35103000.0,"investmentAndOtherAssets":591015000.0,"liabilities":546906000.0,"currentLiabilities":433653000.0,"shorTermDept":null,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":null,"fixedLiabilities":113252000.0,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":80000000.0,"netAsset":5465236000.0,"capitalStock":5510938000.0,"capital":6768642000.0,"capitalSurplus":7620510000.0,"accumulatedEarnings":-8877299000.0,"treasuryStock":-915000.0,"valuationAndConversionAdjustments":-52423000.0,"Report abbreviation_y":"q3r","context_y":"当四半期累計期間連結期間","Sales":949069000.0,"costOfSales":566957000.0,"grossProfit":382111000.0,"sgaExpenses":1146703000.0,"salaryAndBenefit":null,"depreciationAndSGA":null,"RDExpenses":495685000.0,"operatingIncome":-764592000.0,"nonOperatingIncome":155393000.0,"nonOperatingExpenses":48393000.0,"interestExpense":241000.0,"ordinaryProfit":-657592000.0,"extraordinaryGain":null,"extraordinaryLoss":null,"incomeBeforeTax":-657592000.0,"incomeTaxes":1297000.0,"netIncome":-658889000.0,"netIncomeAttributableToOwnersOfTheParentCompany":-658222000.0,"comprehensiveIncome":-595219000.0,"eps":-9.22,"dilutedEps":null,"dividendPerShare":null,"per":null,"roe":null,"cashFlowFromOperatingActivities":null,"depreciationAndCashflowFromOperatingActivities":null,"cashFlowFromInvestingActivities":null,"cashFlowFromFinancialActivities":null,"changesInCashAndCashEquivalents":null,"列1":"q3r","submitDate":"2021\/2\/12","stockCode":4978,"accountingYear":null,"accountingYearStart":"2020\/4\/1","accountingYearEnd":"2021\/3\/31","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E27585","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":2955,"settlementDate":"2022\/3\/31","submitterName":"株式会社リプロセル","submitterNameEnglish":"ReproCELL Incorporated","submitterNameKana":"カブシキガイシャリプロセル","location":"横浜市港北区新横浜３－８－１１","industory":"化学","corporateNumber":2020000000000.0},{"edinetCode":"E27585","endDate":"2021\/3\/31","Report abbreviation_x":"asr","context_x":"当期連結時点","numberOfEmployee":106.0,"averageTemporaryStaff":7.0,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":5953191.0,"sharesOwendPercent":0.0831,"outstandingShares":null,"numberOfSubsidiary":7.0,"bps":75.17,"equityRatio":0.89,"cashAndCashEquivalents":2601406000.0,"assets":6047488000.0,"currentAssets":5244972000.0,"fixedAsset":802515000.0,"tangibleFixedAssets":173576000.0,"intangibleFixedAssets":36801000.0,"investmentAndOtherAssets":592137000.0,"liabilities":656433000.0,"currentLiabilities":553429000.0,"shorTermDept":null,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":null,"fixedLiabilities":103003000.0,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":80000000.0,"netAsset":5391055000.0,"capitalStock":5423687000.0,"capital":6802191000.0,"capitalSurplus":7654059000.0,"accumulatedEarnings":-9031649000.0,"treasuryStock":-915000.0,"valuationAndConversionAdjustments":-39268000.0,"Report abbreviation_y":"asr","context_y":"当期連結期間","Sales":1286284000.0,"costOfSales":803583000.0,"grossProfit":482700000.0,"sgaExpenses":1530747000.0,"salaryAndBenefit":302414000.0,"depreciationAndSGA":23891000.0,"RDExpenses":662029000.0,"operatingIncome":-1048046000.0,"nonOperatingIncome":310244000.0,"nonOperatingExpenses":50928000.0,"interestExpense":319000.0,"ordinaryProfit":-788730000.0,"extraordinaryGain":null,"extraordinaryLoss":23207000.0,"incomeBeforeTax":-811937000.0,"incomeTaxes":1680000.0,"netIncome":-813618000.0,"netIncomeAttributableToOwnersOfTheParentCompany":-812572000.0,"comprehensiveIncome":-736500000.0,"eps":-11.38,"dilutedEps":null,"dividendPerShare":null,"per":null,"roe":null,"cashFlowFromOperatingActivities":-648883000.0,"depreciationAndCashflowFromOperatingActivities":58787000.0,"cashFlowFromInvestingActivities":-1416764000.0,"cashFlowFromFinancialActivities":4410000.0,"changesInCashAndCashEquivalents":-1984220000.0,"列1":"asr","submitDate":"2021\/6\/28","stockCode":4978,"accountingYear":"第19期（自　2020年４月１日　至　2021年３月31日）","accountingYearStart":"2020\/4\/1","accountingYearEnd":"2021\/3\/31","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E27585","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":2955,"settlementDate":"2022\/3\/31","submitterName":"株式会社リプロセル","submitterNameEnglish":"ReproCELL Incorporated","submitterNameKana":"カブシキガイシャリプロセル","location":"横浜市港北区新横浜３－８－１１","industory":"化学","corporateNumber":2020000000000.0},{"edinetCode":"E27585","endDate":"2021\/6\/30","Report abbreviation_x":"q1r","context_x":"当四半期会計期間連結時点","numberOfEmployee":null,"averageTemporaryStaff":null,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":null,"sharesOwendPercent":null,"outstandingShares":null,"numberOfSubsidiary":null,"bps":null,"equityRatio":0.912,"cashAndCashEquivalents":null,"assets":5878601000.0,"currentAssets":5059981000.0,"fixedAsset":818620000.0,"tangibleFixedAssets":179369000.0,"intangibleFixedAssets":35192000.0,"investmentAndOtherAssets":604058000.0,"liabilities":492371000.0,"currentLiabilities":465013000.0,"shorTermDept":null,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":80000000.0,"fixedLiabilities":27357000.0,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":null,"netAsset":5386229000.0,"capitalStock":5386906000.0,"capital":6846435000.0,"capitalSurplus":7698303000.0,"accumulatedEarnings":-9156917000.0,"treasuryStock":-915000.0,"valuationAndConversionAdjustments":-24236000.0,"Report abbreviation_y":"q1r","context_y":"当四半期累計期間連結期間","Sales":382842000.0,"costOfSales":238232000.0,"grossProfit":144610000.0,"sgaExpenses":421279000.0,"salaryAndBenefit":null,"depreciationAndSGA":null,"RDExpenses":169129000.0,"operatingIncome":-276668000.0,"nonOperatingIncome":154624000.0,"nonOperatingExpenses":157000.0,"interestExpense":80000.0,"ordinaryProfit":-122200000.0,"extraordinaryGain":null,"extraordinaryLoss":null,"incomeBeforeTax":-122200000.0,"incomeTaxes":315000.0,"netIncome":-122515000.0,"netIncomeAttributableToOwnersOfTheParentCompany":-122082000.0,"comprehensiveIncome":-107473000.0,"eps":-1.7,"dilutedEps":null,"dividendPerShare":null,"per":null,"roe":null,"cashFlowFromOperatingActivities":null,"depreciationAndCashflowFromOperatingActivities":null,"cashFlowFromInvestingActivities":null,"cashFlowFromFinancialActivities":null,"changesInCashAndCashEquivalents":null,"列1":"q1r","submitDate":"2021\/8\/13","stockCode":4978,"accountingYear":null,"accountingYearStart":"2021\/4\/1","accountingYearEnd":"2022\/3\/31","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E27585","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":2955,"settlementDate":"2022\/3\/31","submitterName":"株式会社リプロセル","submitterNameEnglish":"ReproCELL Incorporated","submitterNameKana":"カブシキガイシャリプロセル","location":"横浜市港北区新横浜３－８－１１","industory":"化学","corporateNumber":2020000000000.0},{"edinetCode":"E27585","endDate":"2021\/9\/30","Report abbreviation_x":"q2r","context_x":"当四半期会計期間連結時点","numberOfEmployee":null,"averageTemporaryStaff":null,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":6449088.0,"sharesOwendPercent":0.0871,"outstandingShares":null,"numberOfSubsidiary":null,"bps":null,"equityRatio":0.894,"cashAndCashEquivalents":4121457000.0,"assets":6551122000.0,"currentAssets":5777469000.0,"fixedAsset":773653000.0,"tangibleFixedAssets":174241000.0,"intangibleFixedAssets":33553000.0,"investmentAndOtherAssets":565857000.0,"liabilities":676361000.0,"currentLiabilities":656062000.0,"shorTermDept":null,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":80000000.0,"fixedLiabilities":20299000.0,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":null,"netAsset":5874761000.0,"capitalStock":5890520000.0,"capital":835766000.0,"capitalSurplus":5432509000.0,"accumulatedEarnings":-376839000.0,"treasuryStock":-916000.0,"valuationAndConversionAdjustments":-36413000.0,"Report abbreviation_y":"q2r","context_y":"当四半期累計期間連結期間","Sales":989082000.0,"costOfSales":599435000.0,"grossProfit":389647000.0,"sgaExpenses":749102000.0,"salaryAndBenefit":155401000.0,"depreciationAndSGA":null,"RDExpenses":278156000.0,"operatingIncome":-359455000.0,"nonOperatingIncome":164834000.0,"nonOperatingExpenses":6955000.0,"interestExpense":183000.0,"ordinaryProfit":-201576000.0,"extraordinaryGain":null,"extraordinaryLoss":null,"incomeBeforeTax":-201576000.0,"incomeTaxes":749000.0,"netIncome":-202326000.0,"netIncomeAttributableToOwnersOfTheParentCompany":-201513000.0,"comprehensiveIncome":-199428000.0,"eps":-2.79,"dilutedEps":null,"dividendPerShare":null,"per":null,"roe":null,"cashFlowFromOperatingActivities":-140119000.0,"depreciationAndCashflowFromOperatingActivities":27060000.0,"cashFlowFromInvestingActivities":978936000.0,"cashFlowFromFinancialActivities":686319000.0,"changesInCashAndCashEquivalents":1520050000.0,"列1":"q2r","submitDate":"2021\/11\/12","stockCode":4978,"accountingYear":null,"accountingYearStart":"2021\/4\/1","accountingYearEnd":"2022\/3\/31","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E27585","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":2955,"settlementDate":"2022\/3\/31","submitterName":"株式会社リプロセル","submitterNameEnglish":"ReproCELL Incorporated","submitterNameKana":"カブシキガイシャリプロセル","location":"横浜市港北区新横浜３－８－１１","industory":"化学","corporateNumber":2020000000000.0},{"edinetCode":"E27585","endDate":"2021\/12\/31","Report abbreviation_x":"q3r","context_x":"当四半期会計期間連結時点","numberOfEmployee":null,"averageTemporaryStaff":null,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":null,"sharesOwendPercent":null,"outstandingShares":null,"numberOfSubsidiary":null,"bps":null,"equityRatio":0.927,"cashAndCashEquivalents":null,"assets":7809160000.0,"currentAssets":5999747000.0,"fixedAsset":1809413000.0,"tangibleFixedAssets":169025000.0,"intangibleFixedAssets":31141000.0,"investmentAndOtherAssets":1609245000.0,"liabilities":558557000.0,"currentLiabilities":545173000.0,"shorTermDept":null,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":80000000.0,"fixedLiabilities":13384000.0,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":null,"netAsset":7250602000.0,"capitalStock":7295382000.0,"capital":1613106000.0,"capitalSurplus":6209849000.0,"accumulatedEarnings":-526657000.0,"treasuryStock":-916000.0,"valuationAndConversionAdjustments":-56375000.0,"Report abbreviation_y":"q3r","context_y":"当四半期累計期間連結期間","Sales":1488173000.0,"costOfSales":907342000.0,"grossProfit":580830000.0,"sgaExpenses":1110159000.0,"salaryAndBenefit":null,"depreciationAndSGA":null,"RDExpenses":404926000.0,"operatingIncome":-529329000.0,"nonOperatingIncome":183380000.0,"nonOperatingExpenses":5264000.0,"interestExpense":263000.0,"ordinaryProfit":-351213000.0,"extraordinaryGain":null,"extraordinaryLoss":null,"incomeBeforeTax":-351213000.0,"incomeTaxes":1332000.0,"netIncome":-352545000.0,"netIncomeAttributableToOwnersOfTheParentCompany":-351331000.0,"comprehensiveIncome":-369498000.0,"eps":-4.74,"dilutedEps":null,"dividendPerShare":null,"per":null,"roe":null,"cashFlowFromOperatingActivities":null,"depreciationAndCashflowFromOperatingActivities":null,"cashFlowFromInvestingActivities":null,"cashFlowFromFinancialActivities":null,"changesInCashAndCashEquivalents":null,"列1":"q3r","submitDate":"2022\/2\/10","stockCode":4978,"accountingYear":null,"accountingYearStart":"2021\/4\/1","accountingYearEnd":"2022\/3\/31","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E27585","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":2955,"settlementDate":"2022\/3\/31","submitterName":"株式会社リプロセル","submitterNameEnglish":"ReproCELL Incorporated","submitterNameKana":"カブシキガイシャリプロセル","location":"横浜市港北区新横浜３－８－１１","industory":"化学","corporateNumber":2020000000000.0}]